"Identification of Biomarkers for Early-Stage Hepatocellular Carcinoma (HCC)" aims to address the critical global challenge of late-stage cancer diagnosis, which significantly lowers patient survival rates. It explores microarray gene expression datasets from GEO to identify potential early-stage biomarkers for improved patient outcomes.
-
Updated
Oct 3, 2024 - Jupyter Notebook